Australian Biotech Ecopha Expands into China as Global Demand for Sustainable Plastics Surges

EcoPHA Biotech has officially launched a landmark joint venture in China: Ecopha Biotech (Suzhou) Co., Ltd., marking a pivotal moment in the Australian company’s global expansion. This milestone not only enhances Australia’s leadership in sustainable innovation but also brings its revolutionary bioplastics to one of the world’s fastest-growing markets.

Global Expansion Milestone
The signing ceremony took place in Suzhou, China, with Ecopha’s Co-Founder and CEO Dr. Wilson Ling (front left) present alongside local government officials and strategic partners. The collaboration will see the development of a 10,000-tonne annual capacity PHA production facility in Taihu New City, with manufacturing set to begin by 2026.

PHA (polyhydroxyalkanoate) is a marine-safe, fully biodegradable bioplastic that breaks down in soil and aquatic environments within months, leaving no microplastics behind. Ecopha’s PHA is derived from pongamia oil – a regenerative, non-edible crop native to Australia – offering a truly circular and scalable solution to plastic waste.

“The establishment of Ecopha Biotech (Suzhou) Co., Ltd. is a major milestone in bringing Ecopha’s innovative pongamia-based bioplastic technology to China,” said Dr. Wilson Ling.

“With the country’s growing demand for sustainable materials, this joint venture is well-positioned to scale PHA production and capture emerging market opportunities across food and healthcare packaging.”

What This Means for China
China has made strong moves toward green transformation, including a phased ban on single-use plastics. Ecopha’s entry into the Chinese market comes at the perfect time to support these goals. The Suzhou plant will serve key industries such as:

• Food packaging

• Healthcare materials

• Events and catering

Key Facts:

• Ecopha Biotech (Suzhou) Co., Ltd. is a joint venture with strategic Chinese partners

• 10,000-tonne annual capacity for biodegradable PHA

• Patent-pending pongamia oil-based PHA licensed in China

• Facility will serve China’s food and healthcare packaging demand

• Ecopha already operates in Melbourne, Perth, and Sydney

• PHA market projected to grow from USD $188M (2023) to $367M by 2030

About Ecopha Biotech:
Ecopha Biotech is an Australian climate tech company pioneering marine-safe, plant-based biodegradable plastics. With manufacturing based in Melbourne, R&D in Perth, and design collaborations in Sydney (via Terra Sol), Ecopha is transforming plastic alternatives for high-impact sectors.

Now operating globally, Ecopha is proving how local innovation can scale for global environmental impact.